The Conference aims to provide a platform for domestic clinical trial institutes to understand the global environment and the innovative methods to reasonably carry out the trial design, management, surveillance, implementation, document preservation, and reports in order to not only ensure the protection of subjects and the quality of data but also upgrade the quality and competitiveness of our domestic clinical trials. It includes three sessions, namely “Trends in GCP regulation- the essentials of new ICH E6 addendums and the impacts on GCP inspection,” “Quality management and risk-based approach -from industrial aspects” and “Data integrity in clinical trials.” For more information, please refer to the conference program.
We sincerely look forward to your participation!